Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Duffull

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Clinical Pharmacokinetics|March 24, 2020
An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different EthnicitiesJaydeep Sinha, Hesham S Al-Sallami, Stephen B Duffull
Dementia and Geriatric Cognitive Disorders Extra|March 9, 2016
The Influence of Patient Characteristics on Anticholinergic Events in Older PeopleMohammed Saji Salahudeen, Prasad S Nishtala, Stephen B Duffull
British Journal of Clinical Pharmacology|April 19, 2013
A systematic review and meta-analysis of pharmacist-led fee-for-services medication reviewErnieda Hatah, Rhiannon Braund, June Tordoff, et al.
Intensive Care Medicine|June 23, 2006
Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdoseGeoffrey K Isbister, Lena E Friberg, Stephen B Duffull
Journal of Biopharmaceutical Statistics|December 30, 2011
Evaluation of the pre-posterior distribution of optimized sampling times for the design of pharmacokinetic studiesStephen B Duffull, Gordon Graham, Kerrie Mengersen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 14, 2011
Design of pharmacokinetic studies for latent covariatesChakradhar V Lagishetty, Carolyn V Coulter, Stephen B Duffull
Clinical Pharmacokinetics|May 24, 2020
Authors' Reply to Friesen: "An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different Ethnicities"Jaydeep Sinha, Hesham S Al-Sallami, Stephen B Duffull
Scientific Reports|February 24, 2019
An intact model for quantifying functional selectivityXiao Zhu, David B Finlay, Michelle Glass, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 1, 2014
Parameterisation affects identifiability of population modelsVittal Shivva, Julia Korell, Ian G Tucker, et al.
British Journal of Clinical Pharmacology|January 6, 2011
Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpointStephen B Duffull, Daniel F B Wright, Helen R Winter
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Clinical Pharmacokinetics|March 24, 2020
An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different EthnicitiesJaydeep Sinha, Hesham S Al-Sallami, Stephen B Duffull
Dementia and Geriatric Cognitive Disorders Extra|March 9, 2016
The Influence of Patient Characteristics on Anticholinergic Events in Older PeopleMohammed Saji Salahudeen, Prasad S Nishtala, Stephen B Duffull
British Journal of Clinical Pharmacology|April 19, 2013
A systematic review and meta-analysis of pharmacist-led fee-for-services medication reviewErnieda Hatah, Rhiannon Braund, June Tordoff, et al.
Intensive Care Medicine|June 23, 2006
Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdoseGeoffrey K Isbister, Lena E Friberg, Stephen B Duffull
Journal of Biopharmaceutical Statistics|December 30, 2011
Evaluation of the pre-posterior distribution of optimized sampling times for the design of pharmacokinetic studiesStephen B Duffull, Gordon Graham, Kerrie Mengersen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 14, 2011
Design of pharmacokinetic studies for latent covariatesChakradhar V Lagishetty, Carolyn V Coulter, Stephen B Duffull
Clinical Pharmacokinetics|May 24, 2020
Authors' Reply to Friesen: "An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different Ethnicities"Jaydeep Sinha, Hesham S Al-Sallami, Stephen B Duffull
Scientific Reports|February 24, 2019
An intact model for quantifying functional selectivityXiao Zhu, David B Finlay, Michelle Glass, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 1, 2014
Parameterisation affects identifiability of population modelsVittal Shivva, Julia Korell, Ian G Tucker, et al.
British Journal of Clinical Pharmacology|January 6, 2011
Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpointStephen B Duffull, Daniel F B Wright, Helen R Winter
Pageof 18